Clinical Trials

36 enrolled

GynecologicOther

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

BreastDermatologicGynecologicHead & NeckThoracic

30 enrolled

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05691010 2026-02-04

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

28 enrolled

Phase EARLY_PHASE1 Enrolling by invitation

Endometrial Neoplasms

NCT07316361 2026-01-07

GYNORYLAQ™

40 enrolled

Endometrial Neoplasms

NCT07278986 2025-12-12

CYTALUX ISS

10 enrolled

Endometrial Neoplasms

NCT05320757 2025-06-11

Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients

20 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Endometrial Neoplasms

NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

56 enrolled

CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Phase EARLY_PHASE1 Terminated

2 enrolled

GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT05289648 2024-12-19

NIREC

Phase EARLY_PHASE1 Withdrawn

Phase EARLY_PHASE1 Terminated

Uterine Neoplasms, Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT03514121 2024-11-22

FPA150-001

95 enrolled 36 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT02728830 2024-02-21

A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers

39 enrolled 16 charts

Phase EARLY_PHASE1 Terminated

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Endometrial Neoplasms

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

3 enrolled

Phase EARLY_PHASE1 Unknown

Uterine Neoplasms, Endometrial Neoplasms

NCT05812677 2023-04-14

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

20 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT01979003 2022-02-24

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

100 enrolled 6 charts

Endometrial Neoplasms

NCT02767362 2020-07-07

A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium

24 enrolled

Endometrial Neoplasms

NCT01705288 2020-02-17

Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study

103 enrolled 9 charts

Phase EARLY_PHASE1 Unknown

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04046185 2019-08-06

ECCT

60 enrolled

Endometrial Neoplasms

NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

BreastGenitourinaryGynecologic

2 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms

NCT01205672 2017-06-02

Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer

21 enrolled

Insulin Resistance, Endometrial Neoplasms

NCT01482728 2016-05-13

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

12 enrolled

Endometrial Neoplasms

NCT01911247 2013-07-30

Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer

28 enrolled

Phase EARLY_PHASE1 Withdrawn

Endometrial Neoplasms

NCT01498237 2013-07-11

Photoacoustic Endoscopy in Endometrial Cancer

Phase EARLY_PHASE1 Unknown

Endometrial Neoplasms

NCT01779128 2013-01-30

PET-CT vs. Integrated MR-PET Scanning of GYN Cancers

100 enrolled